> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hospira Recalls Sodium Bicarbonate Lot
- URL: https://www.fdaweb.com/hospira-recalls-sodium-bicarbonate-lot/
- Published: 2016-03-21T12:00:00.000Z
- Updated: 2026-09-14T20:50:19.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5135140

> Hospira has recalled one lot of 8.4% sodium bicarbonate injection (NDC: 0409-6625-02, lot # 56-148-EV, expiry 8/1/2017) due to the presence of a particulate discovered in a single–dose glass fliptop vial. “If the particulate is not observed prior to IV administration and breaks off into smaller particulates, passing through the catheter, it may result in localized inflammation, allergic reaction, including anaphylaxis, granuloma formation or microembolic effects (IV only),” a [recall notice](http://www.fda.gov/Safety/Recalls/ucm491476.htm?ref=fdaweb.com) says. Larger particulates may block the infusion, potentially resulting in a delay in therapy, it says.